Showing 8151-8160 of 8647 results for "".
- VSY Biotechnology’s Rotaryjet Preloaded Injector Registered by the European Patent Institutehttps://modernod.com/news/vsy-biotechnologys-rotaryjet-preloaded-injector-registered-by-the-european-patent-institute/2476791/VSY Biotechnology’s Rotaryjet Preloaded Injector, which contains an accessory system for the storage and injection of an IOL, has been registered by the European Patent Institute (EPI). This newly patented technology minimizes the use of viscoelastic material in IOL implantation. The featu
- Retina Specialist Brett Foxman, MD, Earns U.S. Patent for Scleral Depressorhttps://modernod.com/news/retina-specialist-brett-foxman-md-earns-u-s-patent-for-scleral-depressor/2476788/Brett Foxman, MD, Clinical Service Chief in Ophthalmology at Shore Medical Center in Somers Point, New Jersey, recently won a U.S. patent for his new version of the scleral depressor. Dr. Foxman said after performing thousands of eye surgeries using a tool that had stayed essentially uncha
- Perspective: Protocol V Sheds Light on Managing Mild Diabetic Macular Edemahttps://modernod.com/news/perspective-protocol-v-sheds-light-on-managing-mild-diabetic-macular-edema/2479555/When it comes to the treatment of diabetic macular edema (DME), ophthalmologists have overwhelming evidence to guide their decision-making—but only up to a point. DME consists of three clinical subcategories: center-involved DME (CI-DME) with visual acuity (VA) impairment, CI-DME with good
- Bascom Palmer Eye Institute Ranked Nation’s No. 1 in Ophthalmologyhttps://modernod.com/news/bascom-palmer-eye-institute-ranked-nations-no-1-in-ophthalmology/2476783/U.S News & World Report has once again ranked Bascom Palmer Eye Institute of the University of Miami Health System as the nation’s best in ophthalmology. Recognized as a global leader in vision research, medical education, and patient care, this year marks the 18th time that Bascom P
- Okayama University Research: Prosthetics for Retinal Stimulationhttps://modernod.com/news/okayama-university-research-prosthetics-for-retinal-stimulation/2476774/In a study recently published in Advanced Biomedical Engineering, researchers at Okayama University in Japan report a thin photoelectric film which can stimulate degenerated retinal tissues of the eye. Using electric signals to stimulate tissues is the basis of several medical devic
- Pfizer to Combine Upjohn Off-Patent Drug Business With Mylan Into New Companyhttps://modernod.com/news/pfizer-to-combine-upjohn-off-patent-drug-business-with-mylan-into-new-company/2476776/Pfizer plans to combine its Upjohn off-patent branded and generic established medicines business with Mylan into a new company, the drugmakers announced Monday, confirming a recent report on the matter. Under the all-stock transaction, which has been unanimously approved by the boards of both com
- Omeros’ Omidria Receives Product-Specific J-Code from CMShttps://modernod.com/news/omeros-omidria-receives-product-specific-j-code-from-cms/2476766/Omeros announced that the Centers for Medicare and Medicaid Services (CMS) confirmed its preliminary decision to assign a permanent product-specific Healthcare Common Procedure Coding System (HCPCS) J-code for Omidria (phenylephrine and ketorolac intraocular solution) 1% / 0.3%. Omidria is
- PolyActiva Completes Recruitment in Phase 1 Glaucoma Implant Safety Studyhttps://modernod.com/news/polyactiva-completes-recruitment-in-phase-1-glaucoma-implant-safety-study/2476759/PolyActiva has completed patient enrollment for its phase 1 clinical trial to study safety and tolerability of its biodegradable, slow-release ocular implant for the treatment of glaucoma. Current glaucoma treatment requires eye drops to be administered daily, often multiple times each day
- Study: Female Ophthalmology Residents Perform Fewer Procedureshttps://modernod.com/news/study-female-ophthalmology-residents-perform-fewer-procedures/2476755/A new retrospective analysis show that female ophthalmology residents performed fewer cataract operations and fewer total procedures compared with their male counterparts over a 12-year period. In a study publ
- Bausch + Lomb Introduces 23-Gauge Bi-Blade Dual Port Vitrectomy Cutter for the Stellaris Elite Vision Enhancement Systemhttps://modernod.com/news/bausch-lomb-introduces-23-gauge-bi-blade-dual-port-vitrectomy-cutter-for-the-stellaris-elite-vision-enhancement-system/2476752/Bausch + Lomb announced the introduction of the 23-gauge Bi-Blade dual port vitrectomy cutter for the Stellaris Elite vision enhancement system. The new probe joins the available 25- and 27-gauge Bi-Blade cutters as options in the Bi-Blade portfolio. All Bi-Blade cutters double effective cut rate